Worth reading
75Important
Scored from 4 of 6 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
-3871
¥ million (year-on-year change in revenue)Wording
Conditional
How definitive the wording is.Contents of this document
Financial results presentationThird quarter of the fiscal year ending May 20267 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥17,346 million-18.2%
Operating profit¥-899 million
Ordinary income¥9 million
Net income¥-240 million
Selling, general and administrative expenses¥4,935 million
Gross Profit Margin23.3%. Year-on-year change: not disclosed
Operating profit margin-5.2%. Year-on-year change: -8.6 percentage points
Results for the three months of the current quarterNet sales: ¥6,211 million; gross profit: ¥1,438 million; SG&A expenses: ¥1,678 million; operating loss: ¥239 million; ordinary loss: ¥107 million; net loss attributable to owners of the parent: ¥234 million
Full-year earnings forecastNet sales: ¥24,119 million; operating loss: ¥814 million; ordinary profit: ¥47 million; net income attributable to owners of the parent: ¥30 million
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Progress is within the assumptions of the revised earnings forecastBreakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Net sales: Japan, -¥3,822 million; Asia, -¥142 million; Europe, -¥364 million; North America, +¥132 million; foreign exchange impact, +¥326 million. Operating profit: change in sales of COSEL products, -¥1,801 million; change in sales of PRBX products, +¥70 million; COSEL product cost ratio, -¥150 million; PRBX product variable-cost ratio, +¥105 million; personnel expenses, -¥8 million; depreciation and amortization, -¥7 million; expenses, +¥162 million
Key KPIsA metric the company considers important as a management benchmark.
Orders received, book-to-bill ratio and overseas sales ratioOrders received and order backlog
Trends in orders received and order backlog are shown in units of ¥100 million. Orders received in the third quarter of the fiscal year ending May 2026 were ¥7.71 billionCapital expenditures
¥980 million FY2025 forecast
Annual Dividend
¥55 (interim ¥27, year-end ¥28 planned)Payout ratio
Not disclosed. DOE is 4.1% (FY2025 forecast)| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | Third quarter of the fiscal year ending May 2026 |
| Net Sales | ¥17,346 million (YoY -18.2%) |
| Operating profit | ¥-899 million |
| Ordinary income | ¥9 million |
| Net income | ¥-240 million |
| Gross Profit Margin | 23.3%. Year-on-year change: not disclosed |
| Operating profit margin | -5.2%. Year-on-year change: -8.6 percentage points |
| Selling, general and administrative expenses | ¥4,935 million |
| Results for the three months of the current quarter | Net sales: ¥6,211 million; gross profit: ¥1,438 million; SG&A expenses: ¥1,678 million; operating loss: ¥239 million; ordinary loss: ¥107 million; net loss attributable to owners of the parent: ¥234 million |
| Full-year earnings forecast | Net sales: ¥24,119 million; operating loss: ¥814 million; ordinary profit: ¥47 million; net income attributable to owners of the parent: ¥30 million |
| Self-assessment against the plan | Progress is within the assumptions of the revised earnings forecast |
| Breakdown of Factors Affecting the Change | Net sales: Japan, -¥3,822 million; Asia, -¥142 million; Europe, -¥364 million; North America, +¥132 million; foreign exchange impact, +¥326 million. Operating profit: change in sales of COSEL products, -¥1,801 million; change in sales of PRBX products, +¥70 million; COSEL product cost ratio, -¥150 million; PRBX product variable-cost ratio, +¥105 million; personnel expenses, -¥8 million; depreciation and amortization, -¥7 million; expenses, +¥162 million |
| Key KPIs | Orders received, book-to-bill ratio and overseas sales ratio |
| Annual Dividend | ¥55 (interim ¥27, year-end ¥28 planned) |
| Payout ratio | Not disclosed. DOE is 4.1% (FY2025 forecast) |
| Capital expenditures | ¥980 million (FY2025 forecast) |
| Orders received and order backlog | Trends in orders received and order backlog are shown in units of ¥100 million. Orders received in the third quarter of the fiscal year ending May 2026 were ¥7.71 billion |
Items this document does not state (13)
Progress against full-year forecastSegment resultsUnit price and quantity metricsNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAcquisition of treasury sharesMarket Size / ShareKey points of the Q&ANew initiatives
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The decline in net sales reduced the Company's ability to absorb fixed costs, resulting in lower operating profit. In terms of net sales, demand for semiconductor manufacturing equipment, mainly in Japan, and the reduction of FA-related inventories were cited as recovery factors, while overseas sales were affected by U.S. tariff policy, the sluggish Chinese economy and the sluggish European economy.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.